Samsung Bioepis Receives EU Bevacizumab Approval
Company Gets Fifth Biosimilar Approval By European Commision
With the European Commission’s approval of Aybintio (bevacizumab), Samsung Bioepis now has five approved biosimilars for Europe.
With the European Commission’s approval of Aybintio (bevacizumab), Samsung Bioepis now has five approved biosimilars for Europe.